Tae-You Kim

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen

Eun Ryoung Jang, Soo-Jeong Lim, Kyu Eun Lee et al. · Oncogene · 2003 · 158 citations · Full text

Tumor Biology, Breast Oncology, Histone Deacetylase Inhibitor +11

Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung

Young Tae Kim, Tae-You Kim, Dong Soon Lee et al. · Lung Cancer · 2007 · 100 citations

Surgical Oncology, Medicine, Molecular Changes +9

Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy

Jong Gwang Kim, Baek‐Yeol Ryoo, Bong-Seog Kim et al. · Cancer Chemotherapy and Pharmacology · 2007 · 99 citations

Prognostic Factors, Surgical Oncology, Cisplatin-based Chemotherapy +9

Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors

Jung‐Hyun Park, Sung-Hak Kim, Moon-Chang Choi et al. · Biochemical and Biophysical Research Communications · 2008 · 98 citations

Signal Transduction, Angiogenesis, Pivotal Roles +11

Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer

So‐Youn Jung, Wonshik Han, Jong Won Lee et al. · Annals of Surgical Oncology · 2009 · 87 citations · Full text